[Microbiological studies on 7-acylamido cephalosporanic acid derivatives. 2. Protective effect of 3-substitution products and various salts against infections].
D000588:Amines / Q000627:therapeutic use; D000818:Animals; D002511:Cephalosporins / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004926:Escherichia coli / Q000187:drug effects; D005029:Ethylenediamines / Q000627:therapeutic use; D017053:Infection Control; D007273:Injections, Intramuscular; D051379:Mice; D010068:Oxacillin / Q000494:pharmacology / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000517:prevention & control; D011803:Quinine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013844:Thiazoles / Q000627:therapeutic use
D000588:Amines; D002511:Cephalosporins; D005029:Ethylenediamines; D010648:Phenylacetates; D011804:Quinolines; D013844:Thiazoles; D012964:Sodium; D011803:Quinine; D010068:Oxacillin